New inhaled migraine drug put to the test in healthy volunteers
NCT ID NCT07226362
First seen Nov 10, 2025 · Last updated May 09, 2026 · Updated 23 times
Summary
This study tested a new inhaled powder form of the migraine drug DHE in 44 healthy adults. Researchers compared how the body absorbs the drug when given as an inhaled powder, an IV, or a nasal spray. The goal was to see which method works best and is safe, without treating any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY AND TOLERABILITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alliance for Multispecialty research (AMR)
Knoxville, Tennessee, 37920, United States
Conditions
Explore the condition pages connected to this study.